Share This Article:

Efficacy of Yiqi Fumai (Freeze-Dried Powder) on Ischemic Diastolic Heart Failure

Full-Text HTML Download Download as PDF (Size:3047KB) PP. 75-86
DOI: 10.4236/cm.2014.52009    2,851 Downloads   3,685 Views   Citations

ABSTRACT

Objective: To evaluate the efficacy of Yiqi Fumai freeze-dry powder (YFP) on ischemic diastolic heart failure. Methods: 100 patients diagnosed with unstable angina accompanying ischemic diastolic heart failure (IDHF) were selected randomly. 52 patients with TCM syndrome of qi-yin deficiency were divided into Chinese and Western combination therapy group. 48 patients have no TCM syndrome of qi-yin deficiency, and were treated with standard western medicine. After treatment, Seattle Angina Questionnaire Evaluation, ECG, conventional and stress echocardiography (SE) index, NT-proBNP were compared between before and after treatment. Results: The differences of PL, TS, DP between before and after treatment by YFP were statistically significant (P < 0.05). SE parameters of LVEF, E/A were significantly increase; E/e' decreased. The differences were statistically significant. However, echocardiography parameters showed no significant differences after treatment. After the combination treatment, NT-proBNP level had negative correlation with LVEF, E/A (r = -0.432, -0.643, both P < 0.01). Conclusion: Yiqi Fumai freeze-dry powder is safe and effective to patients with ischemic diastolic heart failure. Stress echocardiography can improve the diagnostic of ischemic diastolic heart failure, and maybe an effectively predict treatment response.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Song, D. , Hu, M. , Han, T. , Zhang, H. , Mao, Y. and Tian, T. (2014) Efficacy of Yiqi Fumai (Freeze-Dried Powder) on Ischemic Diastolic Heart Failure. Chinese Medicine, 5, 75-86. doi: 10.4236/cm.2014.52009.

References

[1] Cardiovascular Medicine Branch of Chinese Medical Doctor Association, Evidence-Based Medicine Branch of Chinese Medical Doctor Association Commition (2007) Guidelines and Consensus on Prevention and Treatment of Cardiovascular Diseases 2007[M]. People’s Medical Publishing House, Beijing, 37-39.
[2] Young, M.N., Shoemaker, M.B., Kurtz, E.G., et al. (2012) Heart Failure with Preserved Left Ventricuiar Function: Diagnosticand Therapeutic Challenges in Patients with Diastolic Heart Failure. The American Journal of the Medical Sciences.
[3] Spertus, J.A., Winders, J.A., Dewhurst, T.A., et al. (1995) Development and Alidation of the Seattle Angina Questionnaire: Journal of the American College of Cardiology, 25, 333-341.
http://dx.doi.org/10.1016/0735-1097(94)00397-9
[4] Yang, W.M. and Zhou, Y.X. (1997) Clinical Observation on Treatment of Chronic Congestive Heart Failure with Shenmai Injection: 62 Cases. Practical Journal of Integrated Traditional Chinese and Western Medicine, 10, 1446.
[5] Wang, J.H. (1994) Handbook of Commonly Used Traditional Chinese Medicine [M]. The Golden Shield Press, Beijing, 112.
[6] Xu, L.H. (2009) Therapeutic Effect of Yiqi Fumai in Patients with Chronic Congestive Heart Faliure. Clinical Medicine, 22, 2418-2419.
[7] Yuan, C.L. and Du, S.L. (2012) Efficacy of Yi Qi Fu Mai Injection on Heart Failure Complicated with Angina Pectoris in Patients with Coronary Heart Disease. Chinese Journal of New Drugs, 1774-1777.
[8] Mao, J.Y., Zhang, B.L. and Wang X.L. (2006) Progress in Mechanism of Shenmai Injection in the Treatment of Heart Failure. Chinese Traditional Patent Medicine, 28, 1801-1803.
[9] Dong, Q.Z., Chen, K.Y. and Tu, X.H. (1984) Hemodynamic Effects of Shengmai Injection in the Treatment of Acute Myocardial Infarction. Chinese Journal of Cardiology, 12, 5-6.
[10] Zhong, Y.S. (1998) Effect of Shengmai Injection on Left Ventricular Volume and Function of Patients with Heart Failure after Acute Myocardial Infarction. Journal of Wuhan Postgraduate Medical College, 26, 1-2.
[11] Zhuang, A.L. and Guan, E.J. (1997) Effect of “Sheng Mai” Injection on Cardiac Function of Patients with Ischemic Heart Disease. Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care, 4, 310-311.
[12] Department of Chest Emergency Coordination Group of the State Administration of Traditional Chinese Medicine Medical Administration. (1995) Clinical and Experimental Studies of Shenmal Injection for Treatment of 219 Cases of Angina Pectoris of CHD. Journal of Emergency in Traditional Chinese Medicine, 4, 152-155.
[13] Meng, Q.Y. (2000) Preliminary Study on Rapid Injection of Shengmai Injection in the Treatment of Hypertensive Emergencies. Hebei Medicine, 6, 133-134.
[14] Xing, W.H. and Chen, X.M. (2004) Feasibility of SF-8 Short Scale for Testing Health Related Quality of Life in Patients with Coronary Heart Disease. Foreign Medical Sciences (Section of cardiovascular), 5, 181-184.
[15] Hao, Y.T., Fang, J.Q., Li, C.X., et al. (1999) World Health Organization. WHOQOL and Its Chinese Version. Foreign Medical Sciences (Section of Social Medicine) 16, 118-122.
[16] Wang, L., Hu, Y.S., Wu, X., et al. (2010) Significances of NT-proBNP and hs-CRP in Heart Failure. National Medical Journal of China, 90, 1635-1636.
[17] Liu, T.X., Kong, S.P., Liao, Z.Y., et al. (1997) Assessment Study on Physical Function and the Quality of Life for CHD Patients with SAQ. Chinese Journal of Behavioral Medical Science, 6, 127-129.

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.